Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus.

While there are other risk factors for thrombosis (including other antiphospholipid subtypes), more frequent testing (not limited to twice over 3 months) for lupus anticoagulant would be useful for identifying more patients with SLE at elevated risk for thrombosis.